Market Overview

According to fortune business insights, the global bone graft substitutes market size was valued at USD 4.29 billion in 2025. The market is projected to grow from USD 4.55 billion in 2026 to USD 7.64 billion by 2034, exhibiting a CAGR of 6.68% during the forecast period. North America dominated the bone graft substitutes market with a market share of 46.34% in 2025.

The analysis shows that the market is growing due to the increasing incidence of bone diseases like infections and tumors, and a rising number of orthopedic surgeries worldwide. The growing demand for synthetic substitutes and an increasing number of product approvals by regulatory authorities are also key factors fueling market growth.

Major Players Profiled in the Market Report:

• Medtronic PLC (Ireland)
• DePuy Synthes Companies (Johnson & Johnson Services, Inc.) (U.S.)
• Stryker (U.S.)
• Zimmer Biomet (U.S.)
• Smith & Nephew plc (U.K.)
• SeaSpine (U.S.)
• AlloSource (U.S.)
• Bioventus (U.S.)
• MTF Biologics (U.S.)
• Orthofix Holdings, Inc. (U.S.)

Segments

Increasing Product Launches to Drive the Synthetic Segment

Based on type, the market is segmented into allograft, synthetic, Demineralized Bone Matrix (DBM), and xenograft. The synthetic segment is projected to hold the largest market share. This dominance is attributed to the increasing prevalence of bone-related diseases and the high demand for synthetic products, driven by benefits such as reduced risk of complications and new product launches by market players.

Growing Adoption in Spinal Surgeries to Propel Spinal Fusion Segment Growth

By application, the market is categorized into spinal fusion, joint reconstruction, foot & ankle, and others. The spinal fusion segment is projected to lead the market, driven by the rising number of patients with spine-related diseases and the introduction of new substitutes specifically for various spinal fusion procedures.

Increasing Orthopedic Procedures to Dominate Hospitals Segment